Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 230,532,462 papers from all fields of science
Search
Sign In
Create Free Account
Immunizing Neoantigen Peptide Antibody
Known as:
Immunizing Peptide Antibody
, Anti-Neoantigen Peptide Antibody
, Anti-Immunizing Neoantigen Peptide Antibody
Expand
Any antibody that recognizes tumor-associated peptide antigens that are in neoantigen peptide-based vaccines.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Immune System Processes
antigen binding
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Probing the increase in neoantigen burden at recurrence in ovarian cancer
Timothy O'Donnell
,
Arun Ahuja
,
A. Snyder
,
Jeff Hammerbacher
2016
Corpus ID: 78423129
2016
2016
Immunotherapy: Clonal neoantigens and immune response: a balancing act
L. Hutchinson
Nature Reviews Clinical Oncology
2016
Corpus ID: 1936909
observed across many cancer types, including lung cancer. While ITH can have an impact on patient response to cancer treatments…
Expand
Review
1999
Review
1999
Immune response to haptenized tumor antigen as possible mechanism of anticancer action of hypoxic bioreductive agents at low doses.
I. Schepetkin
Cancer Biotherapy and Radiopharmaceuticals
1999
Corpus ID: 22452260
Possible anticancer effect mechanism of hypoxic bioreductive agents (HBA) at low nongenotoxic doses are reviewed. Experimental…
Expand
1996
1996
Plasma levels of terminal complement complex in the evaluation of bioincompatibility.
M. Duranay
,
U. Olmez
,
M. Turgay
,
M. Sahin
,
M. Bali
,
Y. Tapiş
Nephron
1996
Corpus ID: 3307929
Dr. Murat Duranay, Ulucanlar Cad 55/15, TR-06660 Ankara (Turkey) Dear Sir, Blood membrane interactions in hemodialysis have been…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE